UAB Joins TAPUR Study


 
Eddy Yang, MD, PhD

The University of Alabama at Birmingham is one of eight new institutions, and the only one from Alabama, selected to participate in the Targeted Agent and Profiling Utilization Registry (TAPUR™) Study run by the American Society of Clinical Oncology, Inc. (ASCO®).

The TAPUR Study is the first clinical trial conducted by ASCO, the world's leading professional organization representing oncologists. This research study focuses on whether specific targeted therapies can benefit more patients outside of FDA-approved uses.

The study now has more than 325 participants enrolled on a study drug, a nearly threefold increase since the trial launched just over a year ago. With a revised protocol to lower the age of eligibility from 18 to 12 years of age, the TAPUR Study will soon extend the opportunity for participation to adolescent patients with advanced cancer where there is a defined adolescent dose for the study drugs.

"The TAPUR Study will add to our expanding portfolio of precision oncology clinical trials," said Eddy Yang, MD, PhD, professor and vice chair of Translational Sciences in the UAB Department of Radiation Oncology. "With the study, we hope to address the important question of whether we can improve clinical outcomes by using tumor profiling to direct targeted cancer therapy."

The TAPUR Study will include patients who have any advanced solid tumor, multiple myeloma, or B cell non-Hodgkin lymphoma and are no longer responding to standard anti-cancer treatment or for whom no acceptable standard treatment is available. In addition, the person's cancer must also have at least one genomic variation that can be targeted with a TAPUR Study drug.

"If a patient has tumor testing results that reveal a genomic variation, the physician will review drugs available on the TAPUR Study that target that variation. The doctor can then choose from one of the drug-cancer-gene matches specified in the study or request a review by the study's Molecular Tumor Board," Yang said.

A total of 17 drugs yielding 15 different targeted therapy options (some drugs are used in combination) are available. Seven pharmaceutical companies are currently participating in the study.

All drugs used in the TAPUR Study are approved by the FDA for the treatment of specific types of cancer. However, the study is researching whether those drugs might work in treating other types of cancer as well.

"It is important to note that not all patients will have a drug-cancer-gene match," Yang said.

Scientists and clinicians are still working to understand which of the genomic variations play a critical role in cancer development. Recently reported genomic profiling studies performed in patients with advanced cancer suggest that actionable genomic variants are found in 20 to 40 percent of patients' tumors.

"The TAPUR Study will help us understand which of the genomic variations can be successfully targeted with FDA-approved cancer drugs," Yang said.

 
Share:

 

More Grand Rounds:

 

Overstreet Joins Burr Forman Health Law Practice

Overstreet Joins Burr Forman Health Law Practice

Adam Overstreet has joined Burr & Forman where he will practice with firm's health care group in Birmingham.

Read More

Cisco names TekLinks South Collaboration Partner of the Year

Cisco recently recognized TekLinks as the South Area Architectural Excellence - Collaboration Partner of the Year.

Read More

DCH Introduces Human Milk Program for Premature Infants

DCH Introduces Human Milk Program for Premature Infants

DCH Health System has launched a donor breast milk program benefitting premature infants in the neonatal intensive care units (NICUs) at DCH Regional Medical Center and Northport Medical Center.

Read More

St. Vincent's Open Urgent Care in Homewood

St. Vincent's Open Urgent Care in Homewood

St. Vincent's Health System recently held a ribbon cutting for the opening of its new St. Vincent's Urgent Care location in Homewood.

Read More

Targeting a MicroRNA Shows Potential to Enhance Effectiveness of Diabetes Drugs

Over the past 15 years, UAB endocrinologist Anath Shalev, MD has unraveled a crucial biological pathway that malfunctions in diabetes.

Read More

Study Finds Dieting Combined with High-Intensity Exercise Helps Reducing Risk of Weight Regain

Researchers at UAB have found that combining a calorie-restricted diet with high-intensity interval training could be a solution for reducing weight regain after weight loss.

Read More

St. Vincent's Primary Care Adds New Physicians

St. Vincent's Primary Care Adds New Physicians

St. Vincent's Primary Care, a service of St. Vincent's Health System, has recently added one existing practice and three new physicians to their network.

Read More

Mona Fouad, MD is Honored

Mona Fouad, MD is Honored

Mona N. Fouad, MD, professor and director of the Division of Preventive Medicine in the UAB School of Medicine, has been elected as a member of the National Academy of Medicine -- one of the highest honors given to a physician or scientist in the United States.

Read More

Wilson Joins Alabama Allergy & Asthma

Wilson Joins Alabama Allergy & Asthma

Lorena Wilson, MD has joined Alabama Allergy & Asthma Center, and is seeing patients at the Homewood, Hoover and Alabaster locations.

Read More

Bryant Promoted to COO of Grandview

Bryant Promoted to COO of Grandview

Justin Bryant has been promoted to Chief Operating Officer of Grandview Medical Center. He succeeds Drew Mason who was recently promoted to CEO.

Read More

UAB Medicine Opens New Outpatient Clinics

UAB Medicine Opens New Outpatient Clinics

UAB has added 28,600 square feet of clinical space with expansion into the John N. Whitaker Building, which sits just east of the Kirklin Clinic parking deck.

Read More

Researchers Awarded $5.7 Million

Researchers Awarded $5.7 Million

Researchers studying methods of exercise delivery and the effects on people living with multiple sclerosis have been awarded $5.7 million in funding by the Patient-Centered Outcomes Research Institute (PCORI).

Read More

Shelby Baptist Obtains New Robotic System

Shelby Baptist Obtains New Robotic System

Shelby Baptist Medical Center has acquired the new da Vinci Xi Surgical System, further complementing the hospital's minimally-invasive robotic surgery capabilities.

Read More

Biotech Veteran Jay Liu Joins Southern Research

Jay Liu, PhD has joined the Southern Research Drug Discovery division as director of technology development and innovation. Liu will seek to expand Southern Research's drug discovery capabilities in areas that include biologics and monoclonal antibodies.

Read More

UAB Breaks Ground on New Facility

UAB has broken ground for a new freestanding emergency department and adjacent medical office building in Gardendale.

Read More

St. Vincent's Health System to Adopt Ascension as Part of its Name

St. Vincent's Health System (STVHS) will add Ascension to its name as part of a national effort to make it clearer for patients to access care.

Read More

UAB Listed in 100 hospitals with Great Heart Programs

Becker's Healthcare has named UAB Hospital to the 2017 edition of its list of "100 hospitals and health systems with great heart programs."

Read More

Blue Cross and Blue Shield of Alabama Partners With axialHealthcare

Blue Cross and Blue Shield of Alabama is partnering with axialHealthcare, a national leader in pain management, to collaborate with Alabama physicians to help curb the opioid epidemic.

Read More

Nephrology Clinic Opens at UAB Medicine-Leeds

Nephrology Clinic Opens at UAB Medicine-Leeds

The UAB Division of Nephrology, part of the School of Medicine, has opened a new weekly patient clinic each Friday at UAB Medicine-Leeds. UAB nephrology physicians Gaurav Jain, MD, and Vinay Narasimha Krishna, MD, will be on-site each Friday to provide care.

Read More

Neurosurgical Associates Performs Alabama's First Robotic Assisted Spinal Fusion Using Intraoperative Imaging

Neurosurgical Associates Performs Alabama's First Robotic Assisted Spinal Fusion Using Intraoperative Imaging

The state's first spine procedure using the Mazor Robotic System in conjunction with intraoperative imaging was recently performed by neurosurgeons with Neurosurgical Associates, PC at St. Vincent's Birmingham.

Read More

 

Email Print
 

Tags:
None
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: